LoQus23 Therapeutics Ltd
www.loqus23.comLoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases.
Read more
LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases.
Read more
Country
City (Headquarters)
Cambridge
Industry
Employees
1-10
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Board Observer
Email ****** @****.comPhone (***) ****-****
Technologies
(9)
Reach decision makers at LoQus23 Therapeutics Ltd
Free credits every month!
LoQus23 Therapeutics Ltd FAQ
Cambridge, United Kingdom
Pharmaceutical Manufacturing
